Imeglimin hydrochloride 500mg tablets are an oral antidiabetic medication used to treat type 2 diabetes mellitus in adults. It acts as a "glimin" class drug, improving insulin sensitivity, enhancing glucose-dependent insulin secretion, and reducing hepatic glucose production. It is usually paired with diet and exercise to improve glycemic control.
Exports To: United States Of America | United Kingdom | Australia | Canada | France
Find products similar to Imeglyn 500 Imeglimin Hydrochloride Tablet
United States Of America | United Kingdom | Australia | Canada | France
Y2A Promeds is a pharmaceutical company committed to delivering safe, effective, and high-quality medicines across various therapeutic categories. Established in 2011, the company focuses on products such as steroids, erectile dysfunction treatments, and pain management medicines to meet diverse healthcare needs. With a strong emphasis on quality control, regulatory compliance, and customer satisfaction, Y2A Promeds ensures that every product meets industry standards. The company works with trusted partners to maintain consistency and availability while keeping affordability in mind. Driven by innovation and integrity, Y2A Promeds aims to build long-term trust and expand its presence in the healthcare sector.
